JP2011509254A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509254A5
JP2011509254A5 JP2010541140A JP2010541140A JP2011509254A5 JP 2011509254 A5 JP2011509254 A5 JP 2011509254A5 JP 2010541140 A JP2010541140 A JP 2010541140A JP 2010541140 A JP2010541140 A JP 2010541140A JP 2011509254 A5 JP2011509254 A5 JP 2011509254A5
Authority
JP
Japan
Prior art keywords
sldlr
use according
body weight
hbv
liver infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010541140A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011509254A (ja
JP5638958B2 (ja
Filing date
Publication date
Priority claimed from IL188628A external-priority patent/IL188628A0/en
Application filed filed Critical
Publication of JP2011509254A publication Critical patent/JP2011509254A/ja
Publication of JP2011509254A5 publication Critical patent/JP2011509254A5/ja
Application granted granted Critical
Publication of JP5638958B2 publication Critical patent/JP5638958B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010541140A 2008-01-07 2009-01-07 ウイルス性肝炎におけるｓＬＤＬＲ Expired - Fee Related JP5638958B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL188628A IL188628A0 (en) 2008-01-07 2008-01-07 Use of soluble ldl-r for viral hepatitis
IL188628 2008-01-07
PCT/IL2009/000023 WO2009087622A2 (en) 2008-01-07 2009-01-07 Sldlr in viral hepatitis

Publications (3)

Publication Number Publication Date
JP2011509254A JP2011509254A (ja) 2011-03-24
JP2011509254A5 true JP2011509254A5 (https=) 2013-11-21
JP5638958B2 JP5638958B2 (ja) 2014-12-10

Family

ID=40691055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010541140A Expired - Fee Related JP5638958B2 (ja) 2008-01-07 2009-01-07 ウイルス性肝炎におけるｓＬＤＬＲ

Country Status (7)

Country Link
US (1) US8293706B2 (https=)
EP (1) EP2229179B1 (https=)
JP (1) JP5638958B2 (https=)
CA (1) CA2710664A1 (https=)
ES (1) ES2400743T3 (https=)
IL (2) IL188628A0 (https=)
WO (1) WO2009087622A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014160088A2 (en) * 2013-03-14 2014-10-02 Rhode Island Hospital, A Lifespan-Partner Treating hepatitis b virus infections
IL298166A (en) * 2020-05-14 2023-01-01 Nutcracker Therapeutics Inc Polynucleotides comprising an antigenic payload
US20260053948A1 (en) * 2022-09-15 2026-02-26 Yeda Research And Development Co. Ltd. Compositions and methods for virotherapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102915A (en) 1992-01-19 2005-12-18 Yeda Res & Dev Soluble ldl receptor and its preparation
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
WO1999038524A2 (en) * 1998-01-29 1999-08-05 Patrick Thomas Prendergast Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation
IL139217A0 (en) * 2000-03-13 2001-11-25 Applied Research Systems Monoclonal antibodies to the human ldl receptor, their production and use
EP1592445A4 (en) * 2000-10-25 2007-01-10 Vincent Agnello METHOD FOR INHIBITING HEPATITIS C VIRUS (HCV) INFECTION AND OTHER FLAVIRIDAE / I FAMILY VIRUSES, AND OTHER BLOODY-VIRUSES COMPLEXING WITH LOW OR VERY LOW DENSITY LIPOPROTEIN DENSITY, BY PREVENTING VIRAL ENTRY IN A CELL

Similar Documents

Publication Publication Date Title
ES2962605T3 (es) Compuestos de pirrolizina sustituidos como inhibidores de la replicación del VHB
CA2960436C (en) Solid forms of a toll-like receptor modulator
AU2022283687B2 (en) Crystalline forms of tenofovir alafenamide
US20200345699A1 (en) Hiv protease inhibitors
JP7649815B2 (ja) ｔｏｌｌ様受容体モジュレーターの固体形態
WO2016105532A1 (en) Fused pyrimidine compounds for the treatment of hiv
EP3356355B1 (en) Compounds and combinations for the treatment of hiv
JP7379529B2 (ja) Ｔｏｌｌ様受容体モジュレーターの固体形態
RU2008126305A (ru) Новый пептид
US11718637B2 (en) Prodrugs of 4′-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the same
CN104968673A (zh) 融合多肽及使用方法
JP2011509254A5 (https=)
JP2006117697A5 (https=)
RU2014111179A (ru) КОНЪЮГАТЫ ИНТЕРФЕРОНА λ1 И ПОЛИЭТИЛЕНГЛИКОЛЯ
JP2018532763A5 (https=)
US20200347036A1 (en) Solid forms of an hiv protease inhibitor
JP2008511559A5 (https=)
NZ774435B2 (en) Therapeutic nuclease compositions and methods